177 related articles for article (PubMed ID: 36755247)
21. Identification of the Prognostic Value and Clinical Significance of Interferon Regulatory Factors (IRFs) in Colon Adenocarcinoma.
Yuemaier M; Zhou Z; Zhou Y; Wu C; Li F; Liang X; Kang H; Shen D; Gao F; Lin J
Med Sci Monit; 2020 Nov; 26():e927073. PubMed ID: 33161410
[TBL] [Abstract][Full Text] [Related]
22. Systematic Analysis of the Prognostic Significance and Roles of the Integrin Alpha Family in Non-Small Cell Lung Cancers.
Huang Y; Guo DM; Bu S; Xu W; Cai QC; Xu J; Jiang YQ; Teng F
Adv Ther; 2023 May; 40(5):2186-2204. PubMed ID: 36892810
[TBL] [Abstract][Full Text] [Related]
23. Identification of a glycolysis- and lactate-related gene signature for predicting prognosis, immune microenvironment, and drug candidates in colon adenocarcinoma.
Liu C; Liu D; Wang F; Xie J; Liu Y; Wang H; Rong J; Xie J; Wang J; Zeng R; Zhou F; Peng J; Xie Y
Front Cell Dev Biol; 2022; 10():971992. PubMed ID: 36081904
[No Abstract] [Full Text] [Related]
24. An Intratumor Heterogeneity-Related Signature for Predicting Prognosis, Immune Landscape, and Chemotherapy Response in Colon Adenocarcinoma.
Liu C; Liu D; Wang F; Xie J; Liu Y; Wang H; Rong J; Xie J; Wang J; Zeng R; Zhou F; Xie Y
Front Med (Lausanne); 2022; 9():925661. PubMed ID: 35872794
[TBL] [Abstract][Full Text] [Related]
25. Construction of a novel choline metabolism-related signature to predict prognosis, immune landscape, and chemotherapy response in colon adenocarcinoma.
Liu C; Liu D; Wang F; Liu Y; Xie J; Xie J; Xie Y
Front Immunol; 2022; 13():1038927. PubMed ID: 36451813
[TBL] [Abstract][Full Text] [Related]
26. System analysis of
Situ Y; Gao R; Lei L; Deng L; Xu Q; Shao Z
Int J Biol Markers; 2022 Jun; 37(2):158-169. PubMed ID: 35254116
[TBL] [Abstract][Full Text] [Related]
27. High expression of PDZ-binding kinase is correlated with poor prognosis and immune infiltrates in hepatocellular carcinoma.
Mu W; Xie Y; Li J; Yan R; Zhang J; Liu Y; Fan Y
World J Surg Oncol; 2022 Jan; 20(1):22. PubMed ID: 35065633
[TBL] [Abstract][Full Text] [Related]
28. Identification and validation of
Li L; Li F; Xu Z; Li L; Hu H; Li Y; Yu S; Wang M; Gao L
Front Pharmacol; 2023; 14():1213891. PubMed ID: 37680718
[No Abstract] [Full Text] [Related]
29. Novel diagnostic biomarkers of oxidative stress, immune- infiltration characteristics and experimental validation of SERPINE1 in colon cancer.
Yuan K; Hu D; Mo X; Zeng R; Wu B; Zhang Z; Hu R; Wang C
Discov Oncol; 2023 Nov; 14(1):206. PubMed ID: 37980291
[TBL] [Abstract][Full Text] [Related]
30. Diagnostic and prognostic values of integrin α subfamily mRNA expression in colon adenocarcinoma.
Gong YZ; Ruan GT; Liao XW; Wang XK; Liao C; Wang S; Gao F
Oncol Rep; 2019 Sep; 42(3):923-936. PubMed ID: 31322253
[TBL] [Abstract][Full Text] [Related]
31. PYCR in Kidney Renal Papillary Cell Carcinoma: Expression, Prognosis, Gene Regulation Network, and Regulation Targets.
Shao Z; Lu L; Cui Y; Deng L; Xu Q; Liang Q; Lu X; Zhang J; Chen J; Situ Y
Front Biosci (Landmark Ed); 2022 Dec; 27(12):336. PubMed ID: 36624948
[TBL] [Abstract][Full Text] [Related]
32. MicroRNA-148a-3p Directly Targets SERPINE1 to Suppress EMT-Mediated Colon Adenocarcinoma Progression.
Hu B; Chen Z; Wang X; Chen F; Song Z; Cao C
Cancer Manag Res; 2021; 13():6349-6362. PubMed ID: 34408494
[TBL] [Abstract][Full Text] [Related]
33. A Novel Hypoxia-Related Gene Signature with Strong Predicting Ability in Non-Small-Cell Lung Cancer Identified by Comprehensive Profiling.
Yang H; Wang Z; Gong L; Huang G; Chen D; Li X; Du F; Lin J; Yang X
Int J Genomics; 2022; 2022():8594658. PubMed ID: 35634481
[TBL] [Abstract][Full Text] [Related]
34. Circadian Clock Genes Are Correlated with Prognosis and Immune Cell Infiltration in Colon Adenocarcinoma.
He A; Huang Z; Zhang R; Lu H; Wang J; Cao J; Feng Q
Comput Math Methods Med; 2022; 2022():1709918. PubMed ID: 35116071
[TBL] [Abstract][Full Text] [Related]
35. System analysis of
Situ Y; Xu Q; Deng L; Zhu Y; Gao R; Lei L; Shao Z
Int J Biol Markers; 2022 Mar; 37(1):90-101. PubMed ID: 34870494
[TBL] [Abstract][Full Text] [Related]
36. Identification of SHCBP1 as a potential biomarker involving diagnosis, prognosis, and tumor immune microenvironment across multiple cancers.
Wang N; Zhu L; Wang L; Shen Z; Huang X
Comput Struct Biotechnol J; 2022; 20():3106-3119. PubMed ID: 35782736
[TBL] [Abstract][Full Text] [Related]
37. High expression of PLAC1 in colon cancer as a predictor of poor prognosis: A study based on TCGA data.
Ren Y; Lv Y; Li T; Jiang Q
Gene; 2020 Dec; 763():145072. PubMed ID: 32827679
[TBL] [Abstract][Full Text] [Related]
38. INSC Is Down-Regulated in Colon Cancer and Correlated to Immune Infiltration.
Yu T; Li D; Zeng Z; Xu X; Zhang H; Wu J; Song W; Zhu H
Front Genet; 2022; 13():821826. PubMed ID: 35664320
[No Abstract] [Full Text] [Related]
39. Upregulation of desmoglein 2 and its clinical value in lung adenocarcinoma: a comprehensive analysis by multiple bioinformatics methods.
Sun R; Ma C; Wang W; Yang S
PeerJ; 2020; 8():e8420. PubMed ID: 32095325
[TBL] [Abstract][Full Text] [Related]
40. Identification of Potentially Functional CircRNA-miRNA-mRNA Regulatory Network in Gastric Carcinoma using Bioinformatics Analysis.
Yang G; Zhang Y; Yang J
Med Sci Monit; 2019 Nov; 25():8777-8796. PubMed ID: 31747387
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]